Français
ItalianoBond Royalty Pharma 5.9% ( US78081BAS25 ) in USD
| Issuer | Royalty Pharma | ||||||||||||||||||||
| Market price |  95.42 % ▼ |
||||||||||||||||||||
| Country |  United States
|
||||||||||||||||||||
| ISIN code |
 US78081BAS25 ( in USD )
|
||||||||||||||||||||
| Interest rate | 5.9% per year ( payment 2 times a year) | ||||||||||||||||||||
| Maturity | 02/09/2054 | ||||||||||||||||||||
|
Prospectus brochure in PDF format |
|||||||||||||||||||||
| Minimal amount | 2 000 USD | ||||||||||||||||||||
| Total amount | 500 000 000 USD | ||||||||||||||||||||
| Cusip | 78081BAS2 | ||||||||||||||||||||
| Standard & Poor's ( S&P ) rating | BBB- ( Lower medium grade - Investment-grade ) | ||||||||||||||||||||
| Moody's rating | Baa2 ( Lower medium grade - Investment-grade ) | ||||||||||||||||||||
| Next Coupon | 02/03/2027 ( In 167 days ) | ||||||||||||||||||||
| Detailed description |
Royalty Pharma is a biopharmaceutical company that invests in and manages royalties from marketed pharmaceutical and biotechnology products. The Bond issued by Royalty Pharma ( United States ) , in USD, with the ISIN code US78081BAS25, pays a coupon of 5.9% per year. The coupons are paid 2 times per year and the Bond maturity is 02/09/2054 The Bond issued by Royalty Pharma ( United States ) , in USD, with the ISIN code US78081BAS25, was rated Baa2 ( Lower medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by Royalty Pharma ( United States ) , in USD, with the ISIN code US78081BAS25, was rated BBB- ( Lower medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||||||||||||||||
| |||||||||||||||||||||